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The mechanism(s) involved in regulation of store operated calcium entry in Darier’s disease (DD) is not known. We
investigated the distribution and function of transient receptor potential canonical (TRPC) in epidermal skin cells. DD
patients demonstrated up-regulation of TRPC1, but not TRPC3, in the squamous layers. Ca2 influx was significantly
higher in keratinocytes obtained from DD patients and showed enhanced proliferation compared with normal keratin-
ocytes. Similar up-regulation of TRPC1 was also detected in epidermal layers of SERCA2/ mice. HaCaT cells expressed
TRPC1 in the plasma membrane. Expression of sarco(endo)plasmic reticulum Ca2 ATPase (SERCA)2 small interfering
RNA (siRNA) in HaCaT cells increased TRPC1 levels and thapsigargin-stimulated Ca2 influx, which was blocked by
store-operated calcium entry inhibitors. Thapsigargin-stimulated intracellular Ca2 release was decreased in DD cells.
DD keratinocytes exhibited increased cell survival upon thapsigargin treatment. Alternatively, overexpression of TRPC1
or SERCA2-siRNA in HaCaT cells demonstrated resistance to thapsigargin-induced apoptosis. These effects were depen-
dent on external Ca2 and activation of nuclear factor-B. Isotretinoin reduced Ca2 entry in HaCaT cells and decreased
survival of HaCaT and DD keratinocytes. These findings put forward a novel consequence of compromised SERCA2
function in DD wherein up-regulation of TRPC1 augments cell proliferation and restrict apoptosis. We suggest that the
anti-apoptotic effect of TRPC1 could potentially contribute to abnormal keratosis in DD.
INTRODUCTION
Darier’s disease (DD) is an autosomal dominant inherited
skin disease, which is characterized by the loss of adhesion
between epidermal cells and abnormal keratinization (Burge
and Wilkinson 1992). Typical histological findings include
focal areas of separation between suprabasal epidermal
cells, unusual dyskeratosis with round dyskeratotic keratin-
ocytes (Munro, 1992). Mutations in the sarco(endo)plasmic
reticulum Ca2 ATPase (SERCA) isoform 2b (SERCA2b)
gene leads to a loss of function, and these mutations have
been shown to cause DD (Sakuntabhai et al., 1999). Most
physiological systems are able to compensate for the loss of
function of SERCA2b, possibly because of expression of
other SERCA isoforms within those tissues (Dhitavat et al.,
2003; Tavadia et al., 2004). However, of the multiple isoforms
of SERCA1, -2, or -3, only SERCA2b is expressed in keratin-
ocytes (Lytton and MacLennan, 1988; Ruiz-Perez et al., 1999).
The mutated SERCA2 fails to sequester cytosolic Ca2 into
the endoplasmic reticulum (ER) lumen, thereby disturb-
ing the otherwise normal Ca2 homeostasis circuitry within
the cells (Zhao et al., 2001; Ahn et al., 2003). Although oral
retinoids, such as isotretinoin, have been shown to reduce
hyperkeratosis (Burge and Wilkinson, 1992), the mechanism
behind dysfunction of SERCA2 resulting in keratosis re-
mains elusive.
Ca2 is an integral signaling element that regulates nu-
merous cellular processes (Clapham, 1995; Berridge et al.,
2000). In skin cells, Ca2 is potentially a vital component for
differentiation, proliferation, and the formation of epithelial
cell junctions (Tavadia et al., 2001). The action of Ca2 ion in
cells is dependent on its cellular concentration as well as its
compartmentalization (Berridge et al., 2000). Ca2 exerts a
biphasic effect on cellular growth, a modest increase in cy-
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tosolic [Ca2]i can promote cell proliferation, whereas rela-
tively high cytosolic [Ca2] can lead to increased mitochon-
drial [Ca2]i and account for the release of proapoptotic
proteins resulting in cell death (Anglade et al., 1997; Tomp-
kins et al., 1997). Cytosolic [Ca2] depends on release from
internal stores, entry from external medium as well as re-
moval of Ca2 via the action of plasma membrane Ca2
ATPase and SERCA pumps (Minke and Cook, 2002; Putney,
2003; Montell, 2005). There is strong evidence that release of
Ca2 from the intracellular stores is initiated by activation of
the G protein-coupled receptor that leads to phosphatidyl-
inositol bisphosphate (PIP2) breakdown and generation of
the second messenger inositol-1,4,5-trisphosphate (IP3). IP3
subsequently binds to its receptor in the ER and induces
release of Ca2 from internal stores. Depletion of the intra-
cellular stores also leads to the opening of the plasma mem-
brane Ca2 channels, referred to as store-operated channel
via an as of yet unknown mechanism (Putney, 2004). Treat-
ment of cells with reagents that cause inhibition of intracel-
lular Ca2 accumulation, such as thapsigargin (Tg; a SERCA
pump blocker) initiates a passive release of Ca2 from the
internal stores (Putney, 2003) and activates the same Ca2
entry pathway. Interestingly, treatment of cells with Tg also
leads to apoptosis and cell cycle arrest. Other receptor-
dependent channels that are not linked to internal Ca2
store depletion are also activated by agonist-stimulated PIP2
hydrolysis.
Mammalian homologues of the Drosophila transient recep-
tor potential (trp) gene have been suggested as components
of plasma membrane Ca2 influx channels (Putney, 2003;
Venkatachalam et al., 2003; Montell, 2005). In recent years, 28
mammalian members of the TRP superfamily have been
identified, which are activated by diverse stimuli including
heat, pressure, activation of G protein-coupled receptors,
and intracellular store depletion (Moran et al., 2004). TRP
channels are involved in a multitude of physiological events,
which include secretion, pain transduction, osmoregulation,
mechanosensitivity, cell growth, and differentiation (Moran
et al., 2004; Pla et al., 2005).
Growth and differentiation of keratinocytes is exquisitely
determined by the [Ca2]i in the medium and the cytosol as
well. However, the mechanism of this Ca2-dependent reg-
ulation is not elaborately investigated. Our previous studies
demonstrated that transient receptor potential canonical
(TRPC)1 functions as store-operated calcium entry (SOCE)
channel (Liu et al., 2000; Singh et al., 2001). Furthermore, a
role of TRPC1 in the proliferation of neuronal and epithelial
cells has been shown (Bollimuntha et al., 2005). Because
SERCA2 are key molecules regulating store-operated cal-
cium entry, the present study was undertaken to determine
the role of TRPC channels in SERCA-compromised skin
cells. Our data demonstrate that epidermal expression of
TRPC1 is significantly increased in skin samples obtained
from DD patients and SERCA/ mice. An increase in Ca2
influx was also seen in DD keratinocytes. As an alternative
approach to SERCA2 dysfunction in DD, expression of
SERCA2-small interfering RNA (siRNA) in a human epider-
mal keratinocyte (HaCaT) cell line also exhibited an increase
in TRPC1 expression and Ca2 entry as well. This Ca2
influx was inhibited by isotretinoin and SOCE blockers.
Importantly, HaCaT cells overexpressing TRPC1 showed
higher levels of the antiapoptotic protein Bcl-xL, whereas no
change in the expression of caspase-8, -9, and Apaf1 proteins
was observed. Also, upon stimulation with Tg, cells overex-
pressing TRPC1 or SERCA-siRNA showed an enhanced ac-
tivation of nuclear factor-B (NF-B) and resistance to apo-
ptosis. This suggests overexpression of TRPC1 confers to an
apoptotic-resistant phenotype in keratinocytes, thereby aug-
menting net cell survival in Tg-induced apoptosis. Together
our data suggest a novel role for TRPC1 in the survival of
keratinocytes with SERCA2 dysfunction. Thus, TRPC1 could
contribute to the skin cell pathologies associated with DD.
MATERIALS AND METHODS
HaCaT, Primary and DD Keratinocytes Culture,
Transformation, and Reagents
HaCaT cells were cultured in DMEM (Invitrogen, Carlsbad, CA) supple-
mented with 10% fetal bovine serum, 1 U/ml penicillin, and 1 g/ml strep-
tomycin, and they were maintained at 37°C with 95% humidified air and 5%
CO2 as described in Boukamp et al. (1988) and Im et al. (2002). Cells were
maintained in complete media, until reaching 90% confluence and then
trypsinized, centrifuged, and resuspended in the same medium as described
above. Primary keratinocytes from normal and DD subjects were grown in
EpiLife medium supplemented with 0.06 mM Ca2 and human keratinocyte
growth supplement (Cascade Biologics, Portland, OR) as described previ-
ously (Foggia et al., 2006). HaCaT cells were infected using adenovirus en-
coding trpc1 gene or SERCA2-siRNA as described previously (Singh et al.,
2001; Seth et al., 2004). Lanthanum chloride (LaCl3) was obtained from Sigma-
Aldrich (St. Louis, MO). Thapsigargin (Tg), 3,5-bistrifluoromethyl pyrazole
(BTP2), and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium] were
obtained from Calbiochem (San Diego, CA), and isotretinoin (Accutane) was
obtained from Hoffman-La Roche (Nutley, NJ).
mRNA Isolation, Synthesis of the First-Strand cDNA, and
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR) Analysis
Total RNA was extracted from HaCaT cells by using TRIzol reagent (Invitro-
gen) and was treated with deoxyribonuclease I (1 U/g RNA; Invitrogen) in
a buffer containing 20 mM Tris-HCl, pH 8.4, 2 mM MgCl2, and 50 mM KCl for
15 min at room temperature. The reaction was terminated by adding 2.5 mM
EDTA and heating at 65°C for 10 min. mRNA was isolated using oligo(dT)
column (QIAGEN, Valencia, CA). First-strand cDNA synthesis and RT-PCR
were performed as described previously (Liu et al., 2000; Bollimuntha et al.,
2005). After 30 cycles of amplifications, 10 l of the RT-PCR product was
analyzed on a 1% agarose gel, cloned into TA cloning vector (Invitrogen), and
confirmed either by sequencing or restriction analysis.
Membrane Preparations and Western Blotting
HaCaT cells were harvested and lysed, and crude membranes were prepared
from cell lysates (Singh et al., 2004). Skin samples (control and DD patients)
were minced and treated with 10 g/ml collagenase P (Hoffman-La Roche)
for 15–30 min, followed by homogenization and membrane isolation as de-
scribed in Liu et al. (2000) and Singh et al. (2004). Protein concentration was
determined by using the Bradford method (Bio-Rad, Hercules, CA). Twenty-
five micrograms of protein from crude membrane or whole cell lysates was
resolved on 10% SDS-PAGE gels, transferred to polyvinylidene difluoride
membranes, and probed with respective antibodies TRPC1 (Liu et al., 2000;
Singh et al., 2001), SERCA2 (Calbiochem), TRPC3 (Singh et al., 2004), actin
(Sigma-Aldrich), -tubulin and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Santa Cruz Biotechnology, Santa Cruz, CA), and Apaf1, caspase-9,
caspase-8, Bcl-xL, and NF-B-p65 subunit (Cell Signaling Technology, Bev-
erly, MA) at (1:1000 dilution). Peroxidase-conjugated respective secondary
antibodies were used to label the proteins. Proteins on the membrane were
detected using West Pico-chemiluminescent substrate (Pierce Chemical, Rock-
ford, IL) and analyzed either using Lumiimager (Hoffman-La Roche) or
developing to x-ray films (Eastman Kodak, Rochester, NY).
Immunolocalization, Confocal Microscopy, and
Hematoxylin and Eosin (H&E) Staining
Human and mouse skin samples were fixed using 5% paraformaldehyde,
embedded in paraffin, and sectioned at 10-m thickness. Individual sections
were deparaffined in dimethylbenzene, rehydrated with a gradation of abso-
lute alcohol through distilled water. Samples were blocked for 20 min with
5% donkey serum in phosphate-buffered saline (PBS) containing 0.5% bovine
serum albumin (BSA) and incubated for 1 h with the desired primary anti-
bodies (TRPC1, TRPC3; generously provided by Dr. Craig Montell, Depart-
ment of Biological Chemistry, Johns Hopkins University, Baltimore, MD, and
SERCA2 at 1:100 dilutions), washed three times, and incubated for 20 min
with the desired fluorescein isothiocyanate (FITC) or rhodamine-conjugated
secondary antibodies (1:100) as described in Liu et al. (2000). The secondary
antibody was then removed by washing (3 times in PBS, 5 min each) and
mounted on glass slides using Citifluor (Electron Microscopy Sciences, Hat-
field, PA).
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For immunofluorescence, HaCaT cells were grown overnight on coverslips,
washed twice with PBS, and fixed for 30 min by using 3% paraformaldehyde.
HaCaT cells used for NF-B-p65 nuclear translocation studies were grown on
35-mm glass-bottomed culture dishes (MatTek, Ashland, MA), stimulated
with 1 M thapsigargin for 30 min or 50 ng/ml tumor necrosis factor (TNF)-
for 30 min before fixing, and permeabilized with 0.1% Triton X-100 in PBS.
Cells were permeabilized using methanol for 5 min at 80°C and blocked as
described above. For TRPC1, TRPC3, SERCA2, hemagglutinin (HA), and
NF-B-p65 staining, cells were treated with the desired antibody at 1:100
dilutions for 1 h. Cells were washed (3 times with PBS 0.5% BSA) and probed
with the required FITC- or rhodamine-conjugated secondary antibody (Jack-
son ImmunoResearch Laboratories, West Grove, PA) as described in Liu et al.
(2000) and Singh et al. (2004). Fluorescence images were taken by using a
confocal laser-scanning microscope (LSM 510 Meta; Carl Zeiss, Thornwood,
NY). Fluorescence values for TRPC1, TRPC3, and SERCA2 staining were
obtained using ImageJ software (National Institutes of Health, Bethesda, ND).
For H&E staining, slides were washed, treated with hematoxylin for 5 min, and
washed twice again with water. Slides were placed in 1% alcohol for 5–10 s,
washed with water, and stained with eosin for 5 min. Slides were again washed
twice dehydrated and mounted; images were taken using an LSM 510 Meta
photomicroscope (Carl Zeiss).
Calcium Measurements
HaCaT cells were cultured on 35-mm glass-bottomed culture dishes (MatTek)
for 24 h and incubated with 2 M Fura-2 acetoxymethyl ester (AM) (Calbio-
chem) for 45 min at 37°C under an atmosphere of 5% CO2, 95% air. The cells
were washed three times with SES buffer with or without 1 mM Ca2 (Liu et
al., 2000). For fluorescence measurements, the fluorescence intensity of Fura-2
AM-loaded cells was monitored using a charge-coupled device camera-based
imaging system (Compix, Cranberry, PA) mounted on an Olympus XL70
inverted microscope (Olympus America, Melville, NY) equipped with a
Olympus 40 (1.3 numerical aperture) fluor objective. A monochrometer
dual wavelength enabled alternative excitation at 340 and 380 nm, whereas
the emission fluorescence was monitored at 510 nm with an Orka imaging
camera (Hamamatsu, Bridgewater, NJ). The images of multiple cells collected
at each excitation wavelength were processed using the Ca2 imaging, PCI
software (Compix) to provide ratios of Fura-2 fluorescence from excitation at
340 nm to that from excitation at 380 nm (F340/F380). Analog plots of the
fluorescence ratio (340/380) in single cells are shown. Area under the curve
for the total Ca2 transients were calculated using SigmaPlot 8.0 (Systat
Software, Point Richmond, CA).
Vybrant and Annexin-V Staining Assay
Vybrant apoptosis assay kit (Invitrogen) or Annexin-V-FLOUS staining kit
(Hoffman-La Roche) were used to evaluate apoptosis as per manufacture’s
instruction. These kits distinguish apoptotic and necrotic cells by propidium
iodide dye and YO-PRO-1 dye or FITC conjugated Annexin-V. The cells were
visualized using a fluorescence microscope with 10 or 40 objectives,
respectively. The dead and necrotic cells exhibit red fluorescence of the
nucleus along with the green fluorescence, whereas apoptotic cells have a
characteristic green fluorescence. The numbers of green cells against total
number of cells (differential interference contrast; DIC) were counted for each
experiment, and the values are represented in terms of number of apoptotic
cells/100 cells counted. The values shown are mean of five individual exper-
iments performed in duplicate.
Cell Viability (MTT) Assay
HaCaT cells were seeded on 96-well plates at a density of 5  104 cells/well.
Cell viability was determined by MTT assay, performed in triplicates, as
described previously (Bollimuntha et al., 2005). After incubation with the
desired drug, 100 l of MTT reagent (0.5 mg/ml MTT in SES buffer containing
10 mM HEPES, 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10
mM glucose, pH 7.4) supplemented with 10% FBS was added to each well and
incubated in a CO2 incubator for 2–4 h. The medium was aspirated from each
well, and the culture plate was dried at 37°C for 1 h. The resulting formazan
dye was extracted with 100 l of 0.04 N HCl in isopropanol, and the absor-
bance was measured in a microplate reader (Molecular Devices, Sunnyvale,
CA) at 570 nm with a background correction at 650 nm. To determine the
proliferation of primary keratinocytes, cells from normal (passages 4 and 5)
and DD subjects (passages 4, 5, and 7) were seeded at a density of 2  104
cell/well in 96-well plates. Forty-eight hours postseeding MTT assay was
performed as mentioned above, except 0.5 mg/ml MTT reagent was made in
the EpiLife medium in which the cells were grown.
Dual-Luciferase Reporter Assay
HaCaT cells were grown to 60% confluence in 12-well plates. Transfection
of reporter constructs was done using Lipofectamine 2000 (Invitrogen), as per
manufacturer’s instructions. Reporter vector mixture containing 1.5 g of
pNFkB-Luc (containing firefly luciferase gene from Photinus Pyralis; Clontech,
Mountain View, CA) and 0.06 g of pRL-TK (containing Renilla luciferase
gene from Renilla reniformis, used as internal control; Promega, Madison, WI)
incubated with required amount Lipofectamine 2000 reagent in serum-free
DMEM was used per well for transfection. Complete DMEM with or without
10 multiplicity of infection (MOI) of adenovirus expressing SERCA-siRNA
was supplemented at 4 h after transfection. After 36–40 h of transfection,
HaCaT cells were stimulated with 1 M Tg or 50 ng/ml TNF- for another
4 h. HaCaT cells were treated for 30 min at 37°C with 100 nM of an NF-B
activation inhibitor (catalog no. 481407; Calbiochem), before stimulation. Af-
ter stimulation, cells were washed twice with ice-cold PBS and lysed with 200
l of the supplied lysis buffer. Dual luciferase assay was performed following
manufacturer’s instructions (Promega). A 20-l aliquot was taken for mea-
suring the respective luciferase activities using a Zylux Femtomaster FB12
luminometer. Protein concentrations were determined using Bio-Rad re-
agents. The normalized reporter activities, indicating relative luciferase units
per microgram of protein, were expressed as -fold induction in luciferase
activity.
Statistics
Data analysis was performed using Origin 7.0 (OriginLab, Northampton,
MA). Statistical comparisons were made using the two-tailed Student’s t test.
Experimental values are expressed as mean  SEM. Differences in the mean
values were considered to be significant at p  0.05.
RESULTS
TRPC1 Is Up-Regulated in DD Patients and SERCA2/
Mice
The expression of TRPC channels in the epidermis of control
and DD patients was investigated. Immunostaining of con-
trol human skin samples using TRPC1 or SERCA2 antibody
resulted in immunoreactivity in the epidermal layers (Figure
1A). Both TRPC1 and SERCA2 were expressed in the pro-
liferating layers of the skin and showed colocalization (Fig-
ure 1, A and B). However, TRPC1 immunoreactivity in DD
patients was significantly increased (1.5-fold; fluorescence
values were 964 81 and 609 65, respectively, as obtained
using an ImageJ software, in DD and control tissues; these
values are averages of 3 independent experiments) (Figure
1E). In contrast, staining with SERCA2 antibody showed a
decrease in its immunoreactivity in DD patients (870  92
compared with control 939 80; these values were obtained
using ImageJ software) (Figure 1E). Overlay of both TRPC1
and SERCA2 showed colocalization in the skin sections of
DD patients (Figure 1B). Interestingly, significant TRPC1
staining was observed in the generative layer of epidermis,
important for cell proliferation. It is important to note that
down-regulation of SERCA2 in cardiac myocytes was
shown to increase TRPC4, and TRPC5 expression; however,
expression of TRPC1 was not measured in that study (Seth et
al., 2004). We also investigated whether TRPC3 level was
changed in DD epidermal tissue. As shown in Figure 1, C
and D, no significant increase in TRPC3 immunoreactivity
was observed (792  62 compared with control 813  51) or
in SERCA2 (as seen in Figure 1, A and B). Although other
TRPC expression has not been assessed as yet in DD tissue,
these data suggest that DD might induce specific effects on
different TRPC channels.
To have more conclusive evidence of these changes, crude
membranes were isolated from skin samples of control and
DD patients, and Western blots were performed using
TRPC1 antibody. DD patients showed an increase in level of
TRPC1 (Figure 1F, middle blot). Whereas a modest decrease
in SERCA2 expression was observed in DD patients (Figure
1F, top blot), probing the same blot for actin showed no
difference in the protein levels (Figure 1F, bottom blot).
Quantification of the TRPC1 band indicated an 1.4-fold
increase in DD patient samples (Figure 1F), which was con-
sistent with the confocal data described above. Although,
the TRPC1 antibody used here is very specific (95% im-
munoreactivity toward TRPC1; Liu et al., 2000; Singh et al.,
2001), similar results were also obtained using another
B. Pani et al.
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TRPC1 antibody [data not shown; generously provided by
Dr. Greg Barritt (Department of Medical Biochemistry,
Flinders University, Adelaide, Australia)]. H&E and DIC
images from skin samples (control and DD patients) were
also examined. Significant abnormalities consistent with the
pathophysiology of DD were detected such as dyskeratosis
(DIC image) with suprabasal acanthyolysis and also hyper-
proliferative budding in the epidermis beneath the dysker-
atotic plugs (H&E staining) (Figure 1G).
To confirm the results obtained with DD patients who
have only one normal copy of the gene encoding SERCA2,
we used epidermal tissue from SERCA2/ mice, which like
DD patients have one normal copy of SERCA2 gene. The
SERCA2 gene was targeted previously by removing the
promoter and first two exons, which eliminated expression
of the mutant gene (Periasamy et al., 1999). Immunolocaliza-
tion was performed on skin samples from SERCA2/ and
SERCA2/ mice. Similar to the results with DD tissue,
TRPC1 protein was up-regulated in the skin sections of
SERCA2/ mice (Figure 2A, red fluorescence), whereas
there was no increase in TRPC3 levels (our unpublished
data). Importantly, increased TRPC1 expression was ob-
served in mouse epidermal layers, which is consistent with
the results obtained from DD patients. Expression of
SERCA2 in the skin cells of SERCA2/ mice was also re-
duced compared with control (Figure 2A, green fluores-
cence). Moreover, Western blots performed on skin samples
obtained from SERCA2/ and SERCA2/ mice showed a
decreased expression of SERCA2 in SERCA2/ mice,
whereas no change in actin levels was observed (Figure 2B).
Overall, these results suggest that a loss of function and/or
reduced expression of SERCA2 increase TRPC1 expression
in epidermal keratinocytes.
Expression of TRPC in Epidermal Keratinocytes
To understand the association between TRPC1 and SERCA2
down-regulation, we used a human keratinocyte (HaCaT) cell
line. The expression of TRPC proteins was assessed by RT-PCR
using TRPC1 and three specific primers (Bollimuntha et al.,
2005). Analysis of the amplified fragments showed that TRPC1
and TRPC3 were expressed in HaCaT cells. Also, plasmid
DNA encoding TRPC1 and TRPC3 genes were used as tem-
plate to amplify the desired fragments using the same primers
(Figure 3A, bottom). GAPDH primers were used as a control,
which showed equal amount of the amplified product in both
the lanes (Figure 3A, middle). As shown in Figure 3A, 455-base
pair TRPC1 and 690-base pair TRPC3 fragments were ampli-
fied from mRNA isolated from HaCaT cells. These PCR prod-
Figure 1. TRPC1 and TRPC3 expression in control and DD patients. Immunofluorescence in skin sections (10 m) obtained from control
(A and C) or DD patient (B and D), using anti-TRPC1 (A and B), anti-SERCA2, and anti TRPC3 (C and D) at 1:100 dilutions. Fluorescently
labeled secondary antibodies were used to label TRPC1, TRPC3, and SERCA2 proteins. Images were taken using 63 objective. (E) Bar graph
indicating immunofluorescence values of SERCA2, TRPC1, and TRPC3 in control and DD patients. (F) Western blot using crude membranes
prepared from control and DD patients and probed using TRPC1, SERCA2, and actin antibodies. (G) Images (H&E staining and DIC) from
control and DD patients.
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ucts matched their respective base pair sizes and were further
confirmed by sequencing (our unpublished data).
Expression of TRPC1 and TRPC3 in HaCaT cells was
further assessed by Western blotting using crude mem-
branes isolated from HaCaT (crude membrane from HSG
cells was used as a control). Specific polyclonal anti-TRPC1
antibodies labeled similar 80-kDa protein bands in these
samples from HaCaT and HSG cells (positive control, Liu et
Figure 2. SERCA2/ mice exhibit increased TRPC1 expression. (A) Immunofluorescence in skin sections (10 m) obtained from
SERCA2/ or SERCA2/ mice using anti-TRPC1 and anti-SERCA2 antibodies. Fluorescently labeled secondary antibodies were used to
label TRPC1 and SERCA2 proteins. Images were taken using 63 objective. (B) Western blots performed on samples obtained from
SERCA2/ and SERCA2/ mice and probed using SERCA2 and -actin antibodies.
Figure 3. Expression of TRPC1 and TRPC3
in HaCaT cells. (A) RT-PCR on HaCaT cells
using trp1- and trp3-specific primers (top) or
GAPDH primers (middle) as described in
Bollimuntha et al. (2005) and Kobayashi et al.
(2003), bottom, is control PCR using plasmid
DNA. (B) Western blot on crude membranes
prepared from HaCaT cells and probed using
TRPC1 or TRPC3 antibodies. Control samples
were obtained from HSG cells expressing
endogenous TRPC1 and 293 cells expressing
endogenous TRPC3. (C) Localization of endog-
enous TRPC1 and TRPC3 in HaCaT and
SERCA2-siRNA–expressing cells using TRPC1
and TRPC3 antibodies followed by rhodamine-
conjugated secondary antibodies. Control indi-
cates staining without TRPC1 or TRPC3 anti-
bodies but treated with rhodamine-labeled
secondary antibody.
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al., 2000; Singh et al., 2001). Similar results were also ob-
tained using two different TRPC1 antibodies (our unpub-
lished data; generously provided by Dr. Greg Barritt). To
establish whether TRPC3 is expressed in these cells, Western
blotting using specific TRPC3 antibody was performed as
described previously (Singh et al., 2004). Both these antibod-
ies were also used for confocal studies as described in Figure
1, A and C. As shown in Figure 3B, TRPC3 was detected in
both HaCaT and human embryonic kidney 293 cells (posi-
tive control; Singh et al., 2004). The TRPC1 and TRPC3 bands
also corresponded to that of the respective HA-tagged pro-
teins expressed in HaCaT cells (our unpublished data), con-
firming that they represent TRPC1 and TRPC3 proteins,
respectively.
Localization of endogenous TRPC1 and TRPC3 proteins in
HaCaT cells was determined by immunofluorescence. Con-
trol HaCaT cells were cultured on glass coverslips for 24 h,
and TRPC1 and TRPC3 proteins were detected using poly-
clonal anti-TRPC1 and -TRPC3 antibodies. Punctate staining
of TRPC1 protein was observed along the plasma membrane
and in the subplasma membrane region, further confirming
the expression of TRPC1 in these cells (Figure 3C). No im-
munoreactivity was observed in the absence of the primary
antibody (Figure 3C). TRPC3 was also detected in the
plasma membrane region, along with some subplasma
membrane staining (Figure 3C). These results are consistent
with our previous results, demonstrating localization of
TRPC1 and TRPC3 in the plasma membrane (Liu et al., 2000;
Singh et al., 2004) and with another report, where TRP
proteins were shown to be expressed in the plasma mem-
brane of normal human keratinocytes (Tu et al., 2005). More-
over, localization of TRPC1 and TRPC3 was not altered in
HaCaT cells overexpressing SERCA2-siRNA (Figure 3C).
Together, the data presented above suggest that TRPC1 and
TRPC3 are expressed in human keratinocytes and can po-
tentially contribute toward regulation of Ca2 entry and
cytosolic [Ca2]. However, because only TRPC1 was up-
regulated in DD, the role of this channel in keratinocyte
growth was further examined.
SERCA2 Gene Silencing Increases Thapsigargin-stimulated
Ca2 Influx and TRPC1 Expression Levels
Keratinocytes from DD patients have only one normal copy
of SERCA2. It has been hypothesized that a single copy of
the gene is insufficient to encode adequate amount of SERCA
protein, and significant changes in cellular Ca2 regulation and
cell growth are seen in these cells (Sakuntabhai et al., 1999;
Ahn et al., 2003; Foggia et al., 2006). To examine the possible
consequences of SERCA2 hypofunction, we knocked down
SERCA2 in HaCaT cells using adenovirus encoding either
SERCA2-siRNA or control-siRNA. HaCaT cells were tran-
Figure 4. Ca2 influx in HaCaT cells and DD keratinocytes. (A) Tg-stimulated fluorescence trace in HaCaT cells transiently expressing
adenovirus encoding control or SERCA2-siRNA (MOI of 10 plaque-forming units/cell) in a Ca2 containing SES media. (B) Traces of
intracellular release (mean traces from 50 cells each). (C) Fluorescence traces of control or cells expressing SERCA2-siRNA or TRPC1 upon
carbachol stimulation. (D) Ca2 influx values measured as area under the curve; number of cells imaged also is labeled. (E) Traces (mean
value of 50–60 cells) in cells pretreated with 1 mM lanthanum for 15 min or 1 M SOCE blocker BTP2 for 60 min. (F) Tg-stimulated
fluorescence trace in keratinocytes isolated from normal and DD patients. (G) Western blots using SERCA2, TRPC1, and actin antibodies and
representative of three to five individual experiments (quantification added to the blot). Asterisk (*) indicates mean values that are
significantly different (p  0.05).
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siently infected with the required adenovirus and Ca2 im-
aging was performed on cells stimulated with Tg. As shown
in Figure 4A, addition of Tg in a Ca2-containing media,
induced an increase in cytosolic Ca2 ([Ca2]i), which was
significantly higher in HaCaT cells expressing SERCA2-
siRNA, whereas no increase in control-siRNA was observed
(Figure 4A). Mean Ca2 influxes (area under the curve) are
shown in Figure 4D. Importantly, release of Ca2 from the
internal stores (measured upon Tg addition in the absence of
external Ca2) was significantly lower in cells overexpress-
ing SERCA2-siRNA, whereas no change was observed in
TRPC1-overexpressing cells (Figure 4B). TRPC1 or SERCA2-
siRNA expressing cells were also stimulated with a musca-
rinic agonist carbachol, which showed a significant increase
in Ca2 influx (Figure 4C). Overexpression of TRPC1 in-
creased Tg-stimulated [Ca2]i influx was also significantly
decreased upon isotretinoin treatment (a medication that
improves DD symptoms; Figure 4D).
Ca2 entry was more directly assessed using Ca2 read-
dition protocol, which showed a decrease in Tg-stimulated
internal release, but an increase in Ca2 influx in SERCA2-
siRNA expressing cells. This increase in Ca2 influx upon
addition of SERCA2-siRNA was blocked with either 100 M
lanthanum (La3; Liu et al., 2000) or a SOCE blocker, BTP2 (1
M for 60 min; He et al., 2005; Figure 4E). Basal Ca2 influx
(measured upon addition of external Ca2 without Tg stim-
ulation) was not altered (our unpublished data). These data
demonstrate that silencing of SERCA2 leads to a decrease in
intracellular Ca2 store content but an increase in Ca2
entry. To have conclusive evidence, keratinocytes from control
and DD patients were cultured and Ca2 imaging was per-
formed. Similar to HaCaT cells, DD keratinocytes showed a
significant increase in Tg-mediated Ca2 influx (40% increase)
compared with control keratinocytes (Figure 4F). These data
confirm our cell line data and together with our confocal data
indicate that increased Ca2 influx in DD is mediated via
TRPC1 channels.
Western blot analysis performed on HaCaT cells tran-
siently overexpressing SERCA2-siRNA confirmed a de-
crease in SERCA2 expression (quantification of bands indi-
Figure 5. Overexpression of TRPC1 restricts
Tg-mediated apoptosis. Marker for apoptosis
(YO-PRO-1) was used to stain control and
TRPC1-overexpressing cells as described in
Bollimuntha et al. (2005). Tg (1 M) was
treated for 0 or 30 min (A). Fluorescence im-
ages of cells stained with YO-PRO-1 were
taken using 10 or 40 objective, and green
cells were counted along with total number of
cells. (B) Fluorescence images of Annexin-V–
positive cells taken immediately using 10 or
40 objectives, and green cells were counted
along with total number of cells. (C) Repre-
sents mean bar graph from1000 cells in each
group. (D) Represents mean bar graph from
800 cells in each group. (E) Western blot on
crude membranes and whole extracts pre-
pared from HaCaT cells or TRPC1-overex-
pressing cells and probed using TRPC1, Bcl-
xL, caspase-8, caspase-9, Apaf-1, and GAPDH
antibodies. Asterisk (*) indicates values signifi-
cantly different from its counterpart (p  0.05).
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cate 65% decrease in SERCA2 protein levels; Figure 4G).
Furthermore, consistent with the data shown in Figure 1
expression of SERCA2-siRNA–treated cells displayed in-
crease in TRPC1 expression (Figure 4G, quantification of
bands indicate 40% increase in TRPC1 protein levels, no
significant change in actin protein was observed). Moreover,
TRPC1 protein levels were unaffected upon isotretinoin
treatment (100 M for 12 h) of control or SERCA2-siRNA
expressing HaCaT cells (Figure 4G, right). These results
suggest that down-regulation of SERCA2 in keratinocytes
alters cellular Ca2 homeostasis, resulting in increased Ca2
entry. We suggest that Ca2 entry can be attributed to the
increase in TRPC1 expression. However, we presently do
not understand how isotretinoin modulates Ca2 entry in
Tg-treated HaCaT cells.
TRPC1 Overexpression Promotes Cell Survival by
Inhibiting Apoptosis
To investigate the effect of altering SERCA2 on cell viability,
we examined Tg-induced apoptosis in HaCaT cells. As
shown in Figure 5A, control HaCaT cells showed little cell
death (YO-PRO-1 staining, 2 cells stained/100 cells, average
data are shown in B). In contrast, cells treated with Tg for 30
min showed a significant increase in cell death (Figure 5, A
and B; Bollimuntha et al., 2005, 30 cells/100 cells, respec-
tively), which did not seem to be dependent on external
Ca2. Strikingly, TRPC1 overexpression significantly de-
creased Tg-induced cell death (80% reduction, 5 cells/100
cells) in normal Ca2-containing medium, more dye uptake
was seen in Tg-treated cells in the absence of external Ca2
(Figure 5, A and B). Addition of necrotic dye propidium
iodide showed no staining under these conditions (our un-
published data); suggesting that Tg induces apoptosis me-
diated cell death.
Because YO-PRO-1 does not differentiate between early
and late apoptosis, we also used FITC-conjugated An-
nexin-V, which binds to the membrane lipid phosphatidyl-
serine with high-affinity upon externalization, an event indic-
ative of early stage of apoptosis before chromatin compaction/
DNA fragmentation and formation of apoptotic bodies.
Staining of HaCaT cells with FITC-conjugated Annexin-V
showed no or insignificant apoptosis for 30 min in the media
devoid of Tg and supplemented with external Ca2 (Figure 5,
C and D). However, addition of Tg significantly increased
apoptosis (20 cells/100 cells), which was decreased in
TRPC1- as well as SERCA2-siRNA–treated cells (80 and
70% reduction, respectively) (Figure 5, C and D). No staining
with propidium iodide was observed (our unpublished
data). An effect due to internal Ca2 store can likely be ruled
out, because cells treated with SECRA2-siRNA have a de-
creased ER Ca2 content, whereas cells overexpressing
TRPC1 treatment have normal Ca2 levels in the store.
Alternatively, the antiapoptotic role of overexpressed
TRPC1 could also be attributed to an altered expression of
Figure 6. Overexpression of SERCA2-siRNA or TRPC1 increases cell proliferation. (A) MTT assays performed on control, TRPC1-, TRPC3-,
and SERCA2-siRNA–overexpressing cells treated with 1 M Tg for 30 min in the absence (left) or presence of 100 M isotretinoin, 12 h (right)
with or without Ca2. (B) Cell survival (MTT assay) on control, TRPC1-, and SERCA2-siRNA–overexpressing cells in the presence of
isotretinoin. (C) Fluorescence images on HaCaT cells overexpressing HA-TRPC1 or endogenous SERCA2, or cells expressing SERC2 siRNA.
TRPC1 was stained using HA antibody (1:500), whereas SERCA2 was stained using SERCA2 antibody (1:1000). Proteins were detected using
FITC-labeled specific secondary antibodies. (D) Cell survival in control and TRPC1-overexpressing HaCaT cell treated with SOCE inhibitor
BTP2 (1 M) and 1 mM La3 for 12 h. (E) Cell proliferation upon 100 M carbachol stimulation for 12 h. (F) Cell survival of keratinocytes
isolated from normal and DD patients, respectively, in presence of 1 M Tg or 100 M isotretinoin for 12 h. Asterisk (*) indicates values
significantly different from its counterpart (p  0.05).
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antiapoptotic proteins, as an outcome for increase in cyto-
solic/nuclear [Ca2]i. Surprisingly, HaCaT cells overex-
pressing TRPC1 (Figure 5E) demonstrated a twofold in-
crease in the levels of total Bcl-xL protein. However, no
change in the levels of caspase-8, -9, and Apaf-1 was ob-
served. Overexpression of TRPC1 was confirmed using
TRPC1 antibody and GAPDH was used as a loading control.
Although changes in the level of other proteins critically
involved in apoptosis and/or cell survival cannot be ex-
cluded, these data reasonably suggest that overexpression of
TRPC1 (either directly or induced as a result of SERCA2
silencing) confers resistance to Tg-induced apoptosis.
To confirm these results, surviving cells were determined
by MTT assay. There was a dose-dependent decrease in cell
survival upon Tg treatment (30 min) (Figure 6A). Consistent
with the protection against apoptosis, SERCA2-siRNA treat-
ment increased cell survival after Tg treatment (Figure 6A).
Keratinocytes overexpressing TRPC1, but not TRPC3,
showed similar increases in cell survival. However, treat-
ment with isotretinoin further decreased cell survival after
treatment with 1 M Tg, which was again increased upon
expression of either TRPC1 or SERCA2-siRNA but not
TRPC3 (Figure 6B). To assess the transfection efficiencies,
confocal studies were performed on cells overexpressing
HA-TRPC1 or SERCA2-siRNA. As indicated in Figure 6C,
staining of HaCaT cells using HA antibody demonstrated a
significant expression (90% cells were positive with HA
antibody). Transfection with SERCA2-siRNA showed 90%
transfection, and consistent with this, there was a significant
reduction in the SERCA2 protein level compared with the
level of SERCA2 in control cells (Figure 6C). Similar
SERCA2-siRNA treatment has been used to effectively de-
crease SERCA2 protein in rat and chicken cardiac myocytes
(Seth et al., 2004). Interestingly, overexpression of TRPC1 or
SERCA2-siRNA expression increased the number of MTT-
positive cells even in cells that were not treated with Tg
(Figure 6B). In contrast, cells treated with isotretinoin
showed a decreased survival (Figure 6B). Addition of BTP2
or La3 (TRPC1 inhibitors) significantly decreased TRPC1-
mediated cell proliferation in HaCaT cells (Figure 6D). Stim-
ulation of cells with muscarinic agonist carbachol also in-
creased cell survival, which was significantly higher in cells
Figure 7. SERCA2-siRNA or TRPC1-mediated protection depends on NF-B stimulation. (A) Fluorescence images on control and TRPC1-
expressing cells treated with 1 M Tg for 30 min and stained using p65 antibody and 4,6-diamidino-2-phenylindole (DAPI) (to counterstain
nucleus). Average data are shown as bar graph. Asterisk (*) indicates values significantly different from its counterpart (p  0.05). (B) TNF-
(50 ng/ml; 4 h) or Tg (1 M; 4 h) stimulated activation of NF-B luciferase reporter construct in control and SERC2-siRNA–expressing HaCaT
cells, in the absence or presence of 100 nM NF-B inhibitor. (C) Cell survival (MTT assay) on control, TRPC1, and SERCA2-siRNA–
overexpressing cells in the absence or presence of 100 nM NF-B inhibitor for 12 h and extracellular Ca2, respectively. (D) Western blots on
control and NF-B inhibitor (100 nM; 12 h)-treated HaCaT cells using TRPC1, SERCA2, and -tubulin antibodies.
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overexpressing TRPC1 or SERCA2-siRNA (Figure 6E).
Moreover, DD keratinocytes also showed significant in-
crease in cell survival both in the presence and absence of Tg
(Figure 6F). Proliferation of normal and DD keratinocytes
was sensitive to isotretinoin treatment (Figure 6F). These
results are consistent with previous studies where TRPC1
inhibited translocation of proapoptotic proteins from the
ER to mitochondria in neuronal cells (Bollimuntha et al.,
2005), and Ca2 influx inhibitors decreased cell proliferation
(Benzaquen et al., 1995) and enhanced apoptosis (Gill et al.,
1996; Enfissi et al., 2004).
TRPC1-mediated Cell Survival Is Dependent on NF-B
Activation
It has been reported that Ca2 is important for activating the
transcription factor NF-B (Miyamoto et al., 1998; Tabary et
al., 2006) and that activation of NF-B followed by the nu-
clear translocation of its transactivating p65 subunit is crit-
ical for cell survival (Lilienbaum and Israel, 2003). Thus, in
order to further substantiate whether overexpression of
TRPC1 could account for the activation of NF-B, confocal
imaging was performed. On stimulation with thapsigargin,
HaCaT cells overexpressing TRPC1 demonstrated an in-
creased (50%) nuclear localization of p65 compared with
control HaCaT cells (Figure 7A). Similar increase in translo-
cation of NF-B was also obtained with HaCaT cells over-
expressing SERCA2-siRNA (average data shown as bar
graph). TNF- (50 ng/ml) stimulation was used as a positive
control for the translocation of p65 (Figure 7A, bar graph).
Moreover, activation of NF-B was assessed using an NF-
B-luciferase reporter construct. This construct was ex-
pressed in HaCaT or SERCA2-siRNA–expressing cells, and
reporter activity was measured using the dual luciferase
reporter assay. SERCA2-siRNA–expressing cells showed a
significant increase (2.5-fold) in reporter activity upon Tg
stimulation, which was inhibited by the addition of NF-B
activation inhibitor (Figure 7B). TNF- was used as a posi-
tive control to stimulate NF-B activation, which also
showed an approximately threefold increase in reporter ac-
tivity that was also inhibited by the addition of NF-B
inhibitor. In addition, basal NF-B activity was also in-
creased in SERCA2-siRNA–expressing cells (our unpub-
lished data). Cell survival assays were performed both in the
presence and absence of NF-B inhibitor on control, TRPC1,
and SERCA2-siRNA expressing cells. Addition of NF-B
inhibitor significantly decreased cell survival in all three sets
of cells, which was also dependent on external Ca2 as a
decrease in cell survival was observed in the absence of
external Ca2 (Figure 7C). Expression of TRPC1 was also
evaluated in the presence of NF-B inhibitor, which showed
that addition of NF-B inhibitor significantly decreases
TRPC1 protein levels, but not SERCA2 levels (Figure 7D).
This supports the finding that TRPC1 promoter has NF-B
responsive elements and that its expression is dependent on
NF-B transactivation (Paria et al., 2003, 2006). These results
confirm that TRPC1-mediated resistance to thapsigargin-
induced apoptosis, in part, associates with the activation of
the NF-B. Our results are also consistent with a previous
report where activation of NF-B has been shown to confer
apoptotic resistance to epidermal keratinocytes (Qin et al.,
1999).
DISCUSSION
The skin is a vital organ that serves multiple functions for
the human body, including serving as insulation and a bar-
rier. Darier’s disease, which is characterized by abnormal
keratosis, is caused by mutations in SERCA2 gene. Al-
though, three isoforms of SERCA (SERCA1, SERCA2, and
SERCA3) are present in mammalian cells, keratinocytes pre-
dominantly expresses SERCA2 isoforms. SERCA is required
for maintaining the ER Ca2 content and is critical for Ca2
homeostasis and Ca2-dependent cell function (Berridge et
al., 2000). Thus, any mutations in SERCA that lead to alter-
ation in function and ER Ca2 store status can impair Ca2-
dependent signaling. Status of the intracellular ER stores is
critical for cell growth and apoptosis (Anglade et al., 1997;
Tompkins et al., 1997). Depletion of intracellular Ca2 stores
also regulates plasma membrane Ca2 entry channels. Ca2
ions have been suggested to be strongly associated with
epidermal differentiation, barrier homeostasis, and forma-
tion of the cornified envelope (Watt, 1989; Nemes and Steinert,
1999). Thus, understanding Ca2 handling in keratinocytes of
the DD disease model will be essential for understanding the
molecular mechanisms involved in the progression of this dis-
ease.
Here, we report for the first time that TRPC1 protein is
up-regulated, in keratinocytes from DD patients. TRPC1 is also
up-regulated in epidermal layers obtained from SERCA/
mice, an animal model for DD. Moreover TRPC1 expression in
squamous layers could be critical for growth and proliferation
of keratinocytes. Similar up-regulation of TRPC1 is seen when
SERCA2 expression is decreased by expression of SERCA2-
siRNA in a human keratinocyte cell line (HaCaT). The effect is
relatively specific, because expression of TRPC3 is not al-
tered. Down-regulation of SERCA2 in HaCaT cells or kera-
tinocytes obtained from DD patients significantly increased
Ca2 influx upon stimulation with Tg without any change in
basal Ca2 influx. Thapsigargin-mediated Ca2 release from
the internal stores was also decreased in SERCA2-siRNA–
expressing cells or in DD keratinocytes, suggesting a de-
creased Ca2 content in the ER store, as a result of compro-
mised SERCA2 activity. Addition of isotretinoin, a drug
used for temporary symptomatic relief of DD, induces a
significant decrease in Ca2 influx in SERCA2-siRNA–ex-
pressing cells without affecting internal Ca2 release or
TRPC1 protein level. Isotretinoin also decreased Tg-stimu-
lated Ca2 entry in cells overexpressing TRPC1. Taken to-
gether, these results demonstrate that down-regulation of
SERCA2 significantly affects plasma membrane Ca2 regu-
lation. Notably, a major consequence of these disruptions in
ER Ca2 signaling is increased Ca2 entry due to an increase
in TRPC1 expression. This leads to higher intracellular
[Ca2] after treatment with Tg.
A key finding of this study is that overexpression of
TRPC1, either directly or via SERCA2-siRNA treatment, in
HaCaT cells confers resistance to Tg-mediated apoptosis and
increases cell survival (Figure 8). Whereas, overexpression
of TRPC3 did not show any increase in cell survival. Fur-
thermore, the protective effect of TRPC1 was associated with
the presence of external Ca2, suggesting a role of Ca2
entry via TRPC1 channel in cell survival. Our study also
indicates that elevation of cytosolic Ca2 as a result of in-
creased SOCE is not associated with apoptosis; instead, it
promotes activation of NF-B pathway leading to an anti-
apoptotic effect. Addition of NF-B inhibitors significantly
decreased TRPC1 levels and also inhibited TRPC1-mediated
cell proliferation, which was dependent on extracellular
Ca2. This indicates that NF-B–induced TRPC1 expression
is critical for cell proliferation/survival. TRPC1 and other
members of its family, involved in SOCE, have been associ-
ated with cell proliferation and the level of expression of
different TRP proteins has been linked with the proliferative
capacity of different cell lineages (Pla et al., 2005). SOCE is
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implicated in activating signaling cascades, influencing cell
division and promoting cell proliferation (Berridge et al.,
2000; Golovina et al., 2001). It has been also reported that
Ca2 is important for activating the transcription factor
NF-B (Miyamoto et al., 1998; Tabary et al., 2006) and that
activation of NF-B followed by the nuclear translocation of
its transactivating p65 subunit is critical for regulation of
apoptosis and cell proliferation (Lilienbaum and Israel,
2003). Increase in Bcl-xL expression in TRPC1 up-regulated
cells further substantiates its transcriptional regulation by
NF-B (Glasgow et al., 2001; Marinari et al., 2004). Increased
expression of Bcl-xL would shift the ratio of pro- and anti-
apoptotic machinery in favor of cell survival; additionally, it
would also work at the level of ER and mitochondria in
regulating Ca2 handling and restoring membrane potential
upon exposure to apoptotic stimuli. Interestingly, histology
of DD skin biopsies also showed hyperproliferative clusters
of cells within the epidermis (Lucker et al., 1996). Moreover,
it has been shown in vitro that Ca2 is important for kera-
tinocyte differentiation and development of intercellular
junctions (Hennings et al., 1980; Elias et al., 2002). Based on
our observation that TRPC1 is overexpressed in the prolif-
erative layer of the epidermis, we suggest that TRPC1-in-
duced resistance to apoptosis might play a role in the ab-
normal keratosis associated with this disease. Interestingly,
Foggia et al. (2006) also showed that capacitative Ca2 influx
was increased in DD patients; however, cytosolic Ca2 was
decreased as a result of overexpressed ATP2C1 (a Golgi
Ca2 pump). These results complement our data and indi-
cate perhaps ATP2C1 and TRPC1 could work together to
maintain Ca2 homeostasis in long-term DD condition;
however, it remains to be investigated whether TRPC1 reg-
ulate or interact with ATP2C1 protein. Together with previ-
ous studies showing up-regulation of TRPC4 and TRPC5
after SERCA2 knockdown in myocytes (Seth et al., 2004), the
present data reveal an interesting communication between
the ER and plasma membrane. One possible role for in-
creased TRPC1 expression after loss of SERCA2 would be to
increase Ca2 entry in order to maintain [Ca2]i. In addition,
the novel data reported here demonstrate that TRPC1 up-
regulation exerts a prosurvival effect on keratinocytes. Thus,
remodeling of Ca2 signaling pathways can compensate for
the aberrant SERCA2 function and the resulting deleterious
consequences on cell growth and survival via upregulation
of “prosurvival” proteins. Although, there are likely to be
multiple genes that are altered under these conditions, our
data provide a novel “cross-talk” between SERCA2 and
TRPC1 and that the antiapoptotic message generated from
this communication upon cell stress is relayed to the nu-
cleus, at least in part, via the NF-B mechanism (Figure 8).
SERCA2 down-regulation has been shown to induce Ca2-
dependent transcriptional and nuclear factors activity (Seth
et al., 2004). Further studies in this regard will be required to
determine the exact mechanisms by which SERCA2 down-
regulation leads to the up-regulation of TRPC1 proteins. For
example it would be important to determine whether
SERCA2-associated transcription factors are also involved in
TRPC1 gene expression. Another important question that
remains to be elaborated is how exactly up-regulation of
TRPC1 would lead to an increase in cell survival and resis-
tance to apoptosis. Such information will be useful in un-
derstanding the mechanisms involved in hypertrophy and
hyperplasia and defining the role of TRPC channels in these
processes.
In summary, we report that dysfunction of Ca2 ho-
meostasis in DD is associated with remodeling of Ca2
homeostasis. We have identified that TRPC1 is up-regulated
in keratinocytes from patients with DD or SERCA/ mouse
model of the disease. Increase in TRPC1 protein is associated
with an increase in Tg-stimulated Ca2 entry. Importantly,
increase in TRPC1 expression in human keratinocytes con-
fers resistance to apoptosis by activation of NF-B and pro-
motes cell survival that is Ca2 dependent. Addition of
isotretinoin, a compound used to treat DD symptoms, de-
creases TRPC1-associated Ca2 influx as well as skin cell
viability. Thus, we propose that up-regulation of TRPC1
contributes to the abnormal keratosis associated with DD.
Therapeutic modulation of TRPC1 could be a potential
treatment for suppressing keratinocyte proliferation DD
patients.
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